Sarepta Therapeutics (SRPT) had the highest return in Q3 2012 by a mid-cap US stock, returning 321.2%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Sarepta Therapeutics (SRPT) | Q3 2012 | 321.21% |
Catalyst Pharmaceuticals (CPRX) | Q3 2012 | 196.08% |
Centerra Gold (CGAU) | Q3 2012 | 70.72% |
Skeena Resources (SKE) | Q3 2012 | 64% |
First Majestic Silver (AG) | Q3 2012 | 61.01% |
SkyWest (SKYW) | Q3 2012 | 59.54% |
Archrock (AROC) | Q3 2012 | 59.06% |
IES (IESC) | Q3 2012 | 58.54% |
Nexstar Broadcasting (NXST) | Q3 2012 | 56.41% |
Fortuna Silver Mines (FSM) | Q3 2012 | 53.76% |
KB Home (KBH) | Q3 2012 | 48.94% |
VEON (VEON) | Q3 2012 | 44.95% |
ACADIA Pharmaceuticals (ACAD) | Q3 2012 | 44.57% |
Lithia Motors (LAD) | Q3 2012 | 44.2% |
Perpetua Resources (PPTA) | Q3 2012 | 43.33% |
SSR Mining (SSRM) | Q3 2012 | 43% |
Mueller Water Products (MWA) | Q3 2012 | 42.26% |
Riot Blockchain (RIOT) | Q3 2012 | 41.33% |
Civitas Resources (CIVI) | Q3 2012 | 41.25% |
Green Brick Partners (GRBK) | Q3 2012 | 40.83% |
Sirius XM (SIRI) | Q3 2012 | 40.76% |
Westlake Chemical (WLK) | Q3 2012 | 39.17% |
Sonic Automotive (SAH) | Q3 2012 | 38.62% |
Repligen (RGEN) | Q3 2012 | 38.6% |
Steven Madden (SHOO) | Q3 2012 | 37.27% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
